Company Search:
Advanced Search
Sponsored Links
Amgen Inc. Company Snapshot
Amgen Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other pharmaceutical manufacturers in North America: Abbott Laboratories (2015 sales of $20.41 billion of which 34% was Nutritionals), Eli Lilly and Company ($19.96 billion of which 35% was Endocrinology), and Abbvie Inc ($22.86 billion of which 100% was Pharmaceutical Products).

Sales Analysis. Amgen Inc. reported sales of $21.66 billion for the year ending December of 2015. This represents an increase of 8.0% versus 2014, when the company's sales were $20.06 billion. Sales at Amgen Inc. have increased during each of the previous five years (and since 2010, sales have increased a total of 44%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Amgen Inc.
  Stock Performance Chart for Amgen Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 156.12
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks 4.5%  
4 Weeks -3.6%   52 Weeks 3.2%  
Amgen Inc. Key Data:
  Ticker: AMGN Country: United States
  Exchanges: NAS FRA HKG MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 21,662,000,000
(Year Ending Jan 2016).
Employees: 17,900
  Currency: U.S. Dollars Market Cap: 116,141,176,485
  Fiscal Yr Ends: December Shares Outstanding: 743,922,473
  Share Type: Common Closely Held Shares: 2,215,988
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.